Back to Results
First PageMeta Content
Biology / Peginterferon alfa-2a / Interferon / Hepatitis C and HIV co-infection / Ribavirin / Peginterferon alfa-2b / Hepatitis C virus / Pegylated interferon / Hepatitis C / Antivirals / Pharmacology / Medicine


HCV Treatment: Interferon and Ribavirin
Add to Reading List

Document Date: 2014-09-18 02:16:23

Open Document

File Size: 552,20 KB

Share Result on Facebook

Company

HCSP Publications / Genentech / Merck / Teva / Three Rivers Pharmaceutical / Rebetol Merck Copegus Roche Ribasphere Three Rivers Pharmaceuticals LLC / Valeant / Alteon Inc. / Schering / /

Event

FDA Phase / /

IndustryTerm

HCV therapy / chemical messengers / food / ready-made solution / treatment of HCV / HCV therapies / HCV Treatment / treatment for hepatitis C / interferon product / /

MedicalCondition

headaches / HIV / viral infection / flu / hepatitis C. But / HCV genotype 1 / nausea / hepatitis C / hepatitis B / HCV genotype 2 / tumor / cancer / muscle pain / HCV / fever / hepatitis C virus. infection / hepatitis C. There / compensated cirrhosis / flu virus / infection / chronic hepatitis B / HCV RNA / /

MedicalTreatment

immunosuppression / /

Organization

FDA / /

Person

Paula Fener / C.D. Mazoff / Alan Franciscus / /

/

Position

Editor-in-Chief / /

Product

Infergen / polyethylene glycol / Ribasphere / peginterferon / Copegus / Ribavirin / Pegasys / Rebetol / Intron A / IL-29 / Peg-Intron / /

Technology

alpha / genotype / /

URL

www.3riverspharma.com/pat_riba.htm / www.beincharge.com / www.infergen.com/7-Resources/1-Aspire.html / www.pegassist.com / www.hcvadvocate.org / /

SocialTag